Rob Oldfield
Well-Known Member
- Relationship to Diabetes
- Type 1
Hate the 'artificial pancreas' phrase but a definite step forward.
Not sure what the implications of "Currently, the average annual cost for the technology is £5,744, higher than Nice considers a cost-effective use of NHS resources." is going to be. Approved but not cost effective?
Not sure what the implications of "Currently, the average annual cost for the technology is £5,744, higher than Nice considers a cost-effective use of NHS resources." is going to be. Approved but not cost effective?
NHS in England to offer artificial pancreas to help manage type 1 diabetes
Successful trial of groundbreaking device, now approved by Nice, uses algorithm to determine amount of insulin needed
www.theguardian.com